From Financial Modeling Prep: 2025-03-12 07:00:01

JAZZ Pharmaceuticals (NASDAQ:JAZZ) has gained 5.29% in the last 30 days, signaling strong investor confidence. The stock is projected to increase by 28.05%, indicating it is undervalued and offers growth potential. JAZZ has a perfect Piotroski Score of 9, showcasing its financial health and operational efficiency in the pharmaceutical industry.



Read more at Financial Modeling Prep:: JAZZ Pharmaceuticals (NASDAQ:JAZZ): A Strong Conte…